Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 87551-87600 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05380713
......SMARTEST Trial......
PHASE2Recruiting
30 participants
Started: May 3, 2022 · Completed: Oct 30, 2028
1 condition2 sponsors1 location
NCT07063940
Home-based EXercise and motivAtional Program Before and After Liver Transplantation
NAActive, not recruiting
269 participants
Started: May 3, 2022 · Completed: May 31, 2026
1 condition1 sponsor3 locations
NCT05087641
A Multicenter, Prospective Trial of the IAB in Adults Suffering From COPD/Emphysema
NAActive, not recruiting
20 participants
Started: May 3, 2022 · Completed: Jan 31, 2027
2 conditions1 sponsor3 locations
NCT05187884
Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma
PHASE2Active, not recruiting
15 participants
Started: May 3, 2022 · Completed: Nov 1, 2025
1 condition1 sponsor2 locations
NCT05296746
Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer
PHASE2Recruiting
1,100 participants
Started: May 3, 2022 · Completed: Dec 1, 2031
1 condition3 sponsors51 locations
NCT05323591
Prospective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France
N/AActive, not recruiting
155 participants
Started: May 3, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor17 locations
NCT05085704
Brain Metabolism Observed at 7 Tesla
N/ARecruiting
20 participants
Started: May 3, 2022 · Completed: Sep 20, 2026
7 conditions1 sponsor1 location
NCT05298423
Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)
PHASE3Active, not recruiting
611 participants
Started: May 3, 2022 · Completed: Aug 19, 2026
1 condition1 sponsor160 locations
NCT05221606
Nurse AMIE (Addressing Malignancies in Individuals Everyday)
NAActive, not recruiting
344 participants
Started: May 3, 2022 · Completed: Mar 31, 2027
1 condition5 sponsors8 locations
NCT05269550
PSMA MRI Guided Prostate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER)
NAActive, not recruiting
50 participants
Started: May 3, 2022 · Completed: Dec 15, 2028
1 condition1 sponsor2 locations
NCT04918186
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
PHASE2Recruiting
60 participants
Started: May 3, 2022 · Completed: Dec 31, 2026
1 condition4 sponsors7 locations
NCT04879329
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
PHASE2Recruiting
372 participants
Started: May 3, 2022 · Completed: Apr 14, 2029
1 condition2 sponsors183 locations
NCT05351424
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
NARecruiting
194 participants
Started: May 3, 2022 · Completed: Dec 31, 2026
2 conditions2 sponsors2 locations
NCT05315414
Multicenter Study to Evaluate the Clinical Outcome of PrimeTaper EV Implant in Single Tooth Restorations
NAActive, not recruiting
138 participants
Started: May 3, 2022 · Completed: May 31, 2029
1 condition1 sponsor5 locations
NCT05366881
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
N/ARecruiting
7,000 participants
Started: May 3, 2022 · Completed: Dec 31, 2026
20 conditions1 sponsor15 locations
NCT05356195
Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)
PHASE3Recruiting
15 participants
Started: May 3, 2022 · Completed: May 31, 2026
5 conditions2 sponsors6 locations
NCT05338385
Readiness Outcomes Affecting Return to Sport 2.0: An Intervention Feasibility & Pilot Study
NAActive, not recruiting
30 participants
Started: May 3, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04657861
APRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple Myeloma
EARLY_PHASE1Recruiting
36 participants
Started: May 3, 2022 · Completed: Aug 20, 2027
2 conditions2 sponsors1 location
NCT06334627
Every Newborn-Reach Up Early Education Intervention for All Children- a Parent Group Intervention for School Readiness in Bangladesh, Nepal, and Tanzania
NAActive, not recruiting
1,651 participants
Started: May 3, 2022 · Completed: Sep 15, 2024
2 conditions5 sponsors3 locations
NCT05369052
Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
PHASE3Recruiting
865 participants
Started: May 3, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor14 locations
NCT05533528
Periodontal Granulation Tissue Preservation in Surgical Periodontitis Treatment
NARecruiting
25 participants
Started: May 3, 2022 · Completed: Feb 1, 2026
3 conditions1 sponsor1 location
NCT05296681
Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery
PHASE2Recruiting
42 participants
Started: May 3, 2022 · Completed: Jul 1, 2025
5 conditions1 sponsor10 locations
NCT05197881
Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix
NARecruiting
125 participants
Started: May 3, 2022 · Completed: Sep 30, 2030
1 condition1 sponsor5 locations
NCT06366802
Cohort Construction and Prognostic Model Construction for Multiple Myeloma
N/AActive, not recruiting
1,000 participants
Started: May 3, 2022 · Completed: May 2, 2027
1 condition1 sponsor1 location
NCT05357638
Physical Training for People With Parkinson's Disease and Multiple Sclerosis: Effect on Mind and Body
NARecruiting
48 participants
Started: May 2, 2022 · Completed: Nov 2, 2025
2 conditions2 sponsors1 location
NCT05019963
Enhancing COVID Rehabilitation With Technology
NAActive, not recruiting
106 participants
Started: May 2, 2022 · Completed: Sep 30, 2024
1 condition3 sponsors1 location
NCT05406856
PROTECT: On-line Adaptive Proton Therapy for Cervical Cancer
NARecruiting
30 participants
Started: May 2, 2022 · Completed: Dec 1, 2026
2 conditions3 sponsors2 locations
NCT05270044
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
PHASE3Active, not recruiting
815 participants
Started: May 2, 2022 · Completed: May 2, 2035
1 condition2 sponsors155 locations
NCT05255302
De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction
PHASE2/PHASE3Recruiting
1,360 participants
Started: May 2, 2022 · Completed: Jun 1, 2029
1 condition1 sponsor44 locations
NCT05258292
Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes
N/ARecruiting
86 participants
Started: May 2, 2022 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT04506606
Cardiac Rehab Effects in HFpEF
NARecruiting
60 participants
Started: May 2, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05622006
Effect of Interrupting Sedentary Time With Different Frequencies of Physical Activity on Cardiometabolic Risk Factors
NAEnrolling by invitation
25 participants
Started: May 2, 2022 · Completed: Oct 30, 2025
3 conditions2 sponsors1 location
NCT06361056
Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials
NARecruiting
80 participants
Started: May 2, 2022 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT05308108
Study of Postoperative Respiratory Complications in Children With Obstructive Sleep Apnea (PORC)
N/ARecruiting
100 participants
Started: May 2, 2022 · Completed: May 31, 2026
3 conditions1 sponsor1 location
NCT04878549
Transcriptomic Responses for the Identification of Pathogens
N/ARecruiting
2,000 participants
Started: May 2, 2022 · Completed: Jun 30, 2025
5 conditions3 sponsors1 location
NCT05269225
Organic Diet in Pregnancy and Risk Markers of Health Effects (The OrgDiet Project)
NARecruiting
100 participants
Started: May 2, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05079984
Agile Development of a Digital Exposure Treatment for Youth With Chronic Musculoskeletal Pain
NAActive, not recruiting
35 participants
Started: May 2, 2022 · Completed: Oct 1, 2025
4 conditions3 sponsors1 location
NCT05199948
Weight, Energy, Lipids, and the Liver (WELL) Study
NAActive, not recruiting
74 participants
Started: May 2, 2022 · Completed: Feb 1, 2026
1 condition1 sponsor1 location
NCT05147298
Community Walks: Clinical Trial
NAActive, not recruiting
543 participants
Started: May 2, 2022 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT05615740
Prevention of Onset and Transition to an Advanced Form of Diabetic Retinopathy in Children
NARecruiting
150 participants
Started: May 2, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05262855
Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma
PHASE2Active, not recruiting
60 participants
Started: May 2, 2022 · Completed: Oct 15, 2025
2 conditions1 sponsor4 locations
NCT04604951
Below the Belt: Non-invasive Neuromodulation to Treat Bladder, Bowel, and Sexual Dysfunction Following Spinal Cord Injury
NARecruiting
40 participants
Started: May 2, 2022 · Completed: Aug 31, 2024
5 conditions4 sponsors2 locations
NCT06588270
Effect of Virtual Reality-based Therapy on Negative Symptoms in People with Schizophrenia
NARecruiting
102 participants
Started: May 2, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05363189
Optimizing Postoperative Recovery After Breast Reconstruction With Autologous Tissue (BestDIEP)
N/ARecruiting
380 participants
Started: May 2, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05039073
Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint Inhibitors
PHASE2Recruiting
46 participants
Started: May 2, 2022 · Completed: Nov 30, 2027
2 conditions2 sponsors2 locations
NCT05364801
Impact of Anxiety on the Decision-making Processes of Anesthesiologists
N/ARecruiting
500 participants
Started: May 2, 2022 · Completed: Oct 31, 2024
3 conditions1 sponsor1 location
NCT05026060
Measurement of Brain Perfusion by a MR Perfusion Imaging Called eASL in Children's Cerebral Arteriopathies.
N/ARecruiting
50 participants
Started: May 2, 2022 · Completed: May 31, 2028
1 condition2 sponsors1 location
NCT03738410
An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS
NARecruiting
80 participants
Started: May 2, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05303805
Topical Sevoflurane for Treatment of Chronic Leg Ulcers
PHASE4Recruiting
50 participants
Started: May 2, 2022 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT05362890
The Role of the Device Operating Under the Continuous Positive Airway Pressure in the Recovery Process of Cochlea
NARecruiting
45 participants
Started: May 2, 2022 · Completed: Nov 30, 2024
1 condition1 sponsor1 location